Published by
@ShahidNShah
@ShahidNShah
505 Penobscot Drive, Redwood City, California, 94063, United States
We are dedicated to helping patients at all stages of cancer live longer and healthier lives through the power of blood tests and the data they unlock from informing better treatment in patients with advanced cancer, to new ways of monitoring recurrence in cancer survivors, and screening to find cancer at its earliest and most treatable in the general population.
Our mission is to conquer cancer with data. It’s an ambitious pursuit. It requires a singular focus, the contributions of many, small steps and bold leaps, and a relentless commitment to patients.
The Guardant360 CDx test is a genomic testing option for solid cancers that has been approved by the FDA. It provides doctors with comprehensive results within a week of a simple blood draw, which …
Posted FDA Breakthrough Device Designation
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm